Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
Viatris (Nasdaq: VTRS) announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026.
Rhea-AI Summary
Viatris (Nasdaq: VTRS) announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026. Company executives will host a conference call and live webcast at 8:30 a.m. ET the same day, accessible via investor.viatris.com and dedicated phone lines.
Positive
- None.
Negative
- None.
Details
News Market Reaction – VTRS
In the Jul 1 session, VTRS gained 1.89%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Quarter reported
- second-quarter 2026
- Upcoming earnings period to be discussed on call
- Earnings release date
- August 6, 2026
- Scheduled date for Q2 2026 results
- Earnings call time
- 8:30 a.m. ET
- Start time for Q2 2026 webcast and conference call
Previous Earnings date Reports
-
Set timing and access details for Q1 2026 results webcast.
-
Announced Q4/FY 2025 results date and separate March 19 investor event.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-second-quarter-2026-financial-results-on-august-6-2026-302814993.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.